Literature DB >> 18486572

Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions.

D McNamara1, E El-Omar.   

Abstract

Helicobacter pylori infection is the most important acquired risk factor for gastric cancer. The infection initiates a chronic inflammatory process that eventually alters the physiology of the gastric environment and leads to achlorohydria. Gastric atrophy may be part of this process but cancer can arise without this precursor. The net effect of decades of inflammation is the establishment of a milieu awash with pro-inflammatory cytokines and characterized by the activation of signalling pathways that cross-talk between inflammation and carcinogenesis. Many of the factors involved in chronic inflammation play a dual role in the process-promoting neoplastic progression but also facilitating cancer prevention. H. pylori bacterial virulence factors as well as host genetic factors play a major role in orchestrating the increased risk of cancer. The study of such host-bacterial interaction is key to uncovering the molecular and cellular pathways involved and will ultimately lead to developing preventive and therapeutic strategies against this global killer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486572     DOI: 10.1016/j.dld.2008.02.031

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  28 in total

1.  IL-1ra anti-inflammatory cytokine polymorphism is associated with risk of gastric cancer and chronic gastritis in a Brazilian population, but the TNF-β pro-inflammatory cytokine is not.

Authors:  J Garcia Oliveira; M Cristina Duarte; A Elizabete Silva
Journal:  Mol Biol Rep       Date:  2012-02-12       Impact factor: 2.316

2.  Cag3 is a novel essential component of the Helicobacter pylori Cag type IV secretion system outer membrane subcomplex.

Authors:  Delia M Pinto-Santini; Nina R Salama
Journal:  J Bacteriol       Date:  2009-10-02       Impact factor: 3.490

3.  The relationship between gastric cancer and Helicobacter pylori in formaldehyde fixed paraffin embedded gastric tissues of gastric cancer patients-scorpion real-time PCR assay findings.

Authors:  Taghi Naserpour Farivar; Pouran Johari; Reza Najafipour; Amir Farzam; Neda Nasirian; Fatemeh HajManouchehri; Hassan Jahani Hashemi; Akram Azimi; Mohammad Bahrami
Journal:  Pathol Oncol Res       Date:  2013-11-01       Impact factor: 3.201

Review 4.  Evolutionary medicine: its scope, interest and potential.

Authors:  Stephen C Stearns
Journal:  Proc Biol Sci       Date:  2012-08-29       Impact factor: 5.349

Review 5.  Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling.

Authors:  Suntaek Hong; Ho-Jae Lee; Seong Jin Kim; Ki-Baik Hahm
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 6.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

7.  Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.

Authors:  Wei Guang; Hua Ding; Steven J Czinn; K Chul Kim; Thomas G Blanchard; Erik P Lillehoj
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

8.  Does the antibody production ability affect the serum anti-Helicobacter pylori IgG titer?

Authors:  Hyun Ah Chung; Sun-Young Lee; Hee Won Moon; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Hye Seung Han
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

9.  Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

Authors:  Fen Wang; Li-Dan Luo; Jian-Hua Pan; Li-Hua Huang; Hong-Wei Lv; Qin Guo; Can-Xia Xu; Shou-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 10.  Tumor-host interactions: the role of inflammation.

Authors:  Marie-Aude Le Bitoux; Ivan Stamenkovic
Journal:  Histochem Cell Biol       Date:  2008-10-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.